Global In Vitro Fertilization (IVF) Services Market

- Opportunity Analysis and Industry Forecast, 2016 - 2025

  • Date December 2016
  • price $3619
 
 

The in vitro fertilization (IVF) services market is expected to touch $23 billion by 2025, growing at a CAGR of 10.3% from 2017 to 2025. In vitro fertilization (IVF) service is the process of artificial fertilization that is used to treat infertility and other genetic problems worldwide.

In vitro fertilization is one of the most competent assisted reproductive technology (ART) that aids couples and single parents globally. However, IVF does not lead to successful results all the time and often depends from individual to individual. The technology has emerged as a preferable choice for fertility treatments in the clinical industry. Around 1.5% babies that are born in the U.S are with the help of IVF. The matured egg (self-egg or donors egg) is fertilized with the sperm (self-sperm or donors sperm) in a clinical laboratory setting. After the previous procedure, the fertilized egg or the embryo is planted into the uterus.

The market is expected to grow owing to reduced conceiving rates, especially in women that are above 40 years of age, ovulation disorder, premature ovarian failure, uterine fibroids, damaged or blocked fallopian tube, endometriosis, impaired sperm production and unexplained fertility. Factors that boost the growth of the market include, increase in government interventions and support, delayed parenthood opted by couples due to professional and financial constraints. However, ethical concerns in particular countries with respect to IVF, high cost of the IVF procedure, followed by low awareness, especially in underdeveloped economies are expected to hinder the market growth.

This report segments the global IVF market on the basis of cycle type, end user, and geography. On the basis of cycle type, the market is classified into fresh cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycles. Fresh cycle (non-donor) is the highest revenue-generating segment, and is expected to maintain this trend with a high growth rate throughout the analysis period as it is the most common method in an IVF process. Similarly, the end users are segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes. The geographical segmentation of the market includes North America, Europe, Asia-Pacific and LAMEA regions.

The report takes into account the costs of IVF procedures and the total revenue generated through IVF procedures. The total number of IVF cycles performed in the regional market is estimated from 2016 to 2025. This report presents data on the number of embryo transfers undergone by patients during IVF procedures. In addition, it depicts the trend analysis in various regions, which is expected to assist key players to plan their strategies. However, this report excludes revenue generated by fertility medications and the costs of other medication incurred during IVF treatments.

Geographical Market Scenario:

Geographically, the market is segmented across North America, Europe, Asia-Pacific, and LAMEA regions. In terms of number of IVF cycles performed, Asia-Pacific is estimated to dominate the IVF market throughout the analysis period and is set to grow at a prominent CAGR of 13.0%, due to wide availability of IVF clinics, high IVF success rates, and the rising trend of fertility tourism. Japan leads the Asia-Pacific IVF services market, accounting for majority of the market share, and is expected to maintain its position during the analysis period. In terms of revenue, Europe dominated the market in 2016, owing to the favorable reimbursement scenario, and is expected to grow at a CAGR of 5.1%, in terms of revenue.

Latin American countries such as Brazil, Colombia, and Venezuela do not provide reimbursements for ART treatment. In Argentina, currently, there is no reimbursement policy available for ARTs; however, partial reimbursements are provided for ovulation induction therapies. Most of the medical treatments in Latin American countries are provided in the public sector. Fertility clinics contributed to highest number of IVF cycles in 2016. Nonetheless, the impending need for advanced IVF treatments is expected to elevate the growth rate of the clinical research institutes segment to 13.1%, which is the fastest amongst other end user segments.

End User Market Scenario:

Fertility clinics accounted for a major market share in 2016, and is projected to maintain this trend over the forecast period. This is attributed to the rise in the number of fertility clinics as well as the availability of a wide range of fertility treatments under a single roof coupled with government reimbursements. Fertility clinics are followed by hospitals, and together they occupied over three-fourths share of the overall market share in 2016.

IN VITRO FERTILIZATION (IVF) SERVICES MARKET KEY BENEFITS

  • The report provides an in-depth analysis of the IVF market across 20 major countries, with a cross-sectional analysis of the number of IVF cycles performed and total revenue generated during the forecast period.
  • The report assists in understanding the strategies adopted by various IVF clinics and hospitals to gain a higher market share.
  • The projections in the report are made by analyzing the current trends and highlighting the market potential from 2016 to 2025 in terms of value and volume.
  • Extensive analysis is carried out by closely following key product positioning and monitoring the top contenders within the market framework.
  • In-depth analysis of insurance reimbursement scenario for the IVF procedure highlights the essential strengths and potential opportunities in the market.

IN VITRO FERTILIZATION (IVF) SERVICES MARKET KEY SEGMENTS:

BY CYCLE TYPE

  • Fresh Cycle (Non-Donor)
  • Thawed IVF Cycle (Non-Donor)
  • Donor Egg IVF Cycle

BY END USER

  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

BY GEOGRAPHY

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Russia
    • Others Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • New Zealand
    • Korea
    • Thailand
    • Others APAC
  • LAMEA
    • Latin America
    • Middle East
    • Africa

Chapter: 1 INTRODUCTION

1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

Chapter: 3 WORLD IN VITRO FERTILIZATION (IVF) MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 IVF Pricing Trends, By Country
3.3 IVF Cycles, By Country
3.4 Global IVF Market, by End User

3.4.1 Fertility Clinics
3.4.2 Hospitals
3.4.3 Surgical Centers
3.4.4 Clinical Research Institutes

3.5 Global IVF Market by Cycle Type

3.5.1 Fresh IVF Cycles (Non-donor)
3.5.2 Thawed IVF Cycles (Non-donor)
3.5.3 Donor Egg IVF Cycles

3.6 Market Dynamics

3.6.1 Drivers

3.6.1.1 Delayed pregnancy
3.6.1.2 Rise in global infertility rates
3.6.1.3 Emergence of new fertility tourism destinations

3.6.2 Restraints

3.6.2.1 High Cost involved in treatment
3.6.2.2 Low level of awareness in developing economies
3.6.2.3 Inadequate reimbursements policies for IVF treatments
3.6.2.4 Ethical Considerations

3.6.3 Opportunities

3.6.3.1 relaxation of legal considerations on ivf treatments
3.6.3.2 New technology development and treatment options
3.6.3.3 Three parent IVF

3.7 Key Findings

Chapter: 4 NORTH AMERICAN IVF MARKET

4.1 U.S.: IVF Market, (Revenue and Number of Cycles)

4.1.1 Number of Infertility Clinics, 2015
4.1.2 U.S. IVF Market, by End Users

4.1.2.1 Fertility clinics
4.1.2.2 Hospitals
4.1.2.3 Surgical centers
4.1.2.4 Clinical research institutes

4.1.3 U.S. IVF Market, by Cycle Type

4.1.3.1 Fresh IVF cycles (non-donor)
4.1.3.2 Thawed IVF cycles (non-donor)
4.1.3.3 Donor egg IVF cycles

4.1.4 Drivers

4.1.4.1 Increasing popularity of IVF in the U.S.
4.1.4.2 Increased rate of infertility and practices of embryo banking cycles

4.1.5 Restraints

4.1.5.1 High cost of IVF treatments in the U.S.
4.1.5.2 Restrictions on three-parent IVF treatments
4.1.5.3 Scattered Reimbursements

4.1.6 Regulatory Issues, Legislations, and Authorities
4.1.7 Insurance Reimbursement Scenario
4.1.8 Company Profile

4.1.8.1 Fertility and Gynecology Center Monterey Bay IVF
4.1.8.2 Conceptions Reproductive Associates
4.1.8.3 Servy Massey Fertility Institute
4.1.8.4 Sher Institute for Reproductive Medicine (SIRM)
4.1.8.5 Cardone Reproductive Medicine & Infertility
4.1.8.6 Fertility Center of San Antonio
4.1.8.7 Houston Fertility Center
4.1.8.8 New hope fertility center
4.1.8.9 Reproductive Medicine Associates Of New Jersey

4.2 Canada IVF Market (Revenue and Number of Cycles)

4.2.1 Number of Infertility Centers
4.2.2 Canadian IVF Market, by End User

4.2.2.1 Fertility clinics
4.2.2.2 Hospitals
4.2.2.3 Surgical centers
4.2.2.4 Clinical research institutes

4.2.3 Canadian IVF Market, By Cycle Type

4.2.3.1 Fresh IVF cycles (non-donor)
4.2.3.2 Thawed IVF cycles (non-donor)
4.2.3.3 Donor egg IVF cycles

4.2.4 Market Dynamics

4.2.4.1 Drivers

4.2.4.1.1 COMMERCIALIZATION OF IVF BOOSTER IN CANADA

4.2.4.2 Restraints

4.2.4.2.1 HIGH COST OF IVF IN CANADA

4.2.5 Regulatory Issues, Legislations and Authorities
4.2.6 Insurance Reimbursement Scenario
4.2.7 Company Profile

4.2.7.1 Toronto Centre for Advanced Reproductive Technology Ltd.
4.2.7.2 Fertility Treatment Center
4.2.7.3 Montreal Fertility Center

4.3 Mexican IVF Market (Revenue and Number of Cycles)

4.3.1 Number of Infertility Centers
4.3.2 Mexico IVF Market by End Users

4.3.2.1 Fertility clinics
4.3.2.2 Hospitals
4.3.2.3 Surgical centers
4.3.2.4 Clinical research institutes

4.3.3 Mexico IVF market by cycle type

4.3.3.1 Fresh IVF cycles (non-donor)
4.3.3.2 Thawed IVF cycles (non-donor)
4.3.3.3 Donor egg IVF cycles

4.3.4 Market Dynamics

4.3.4.1 Drivers

4.3.4.1.1 FERTILITY TOURISM
4.3.4.1.2 COMPARATIVELY LOW COST OF IVF

4.3.4.2 Restraints

4.3.4.2.1 LANGUAGE BARRIERS

4.3.5 Regulatory Issues, Legislations, and Authorities
4.3.6 Insurance Reimbursement Scenario
4.3.7 Company Profile

4.3.7.1 Liv Fertility Center In Puerto Vallarta
4.3.7.2 BFC Biofertility Center

Chapter: 5 EUROPE IVF MARKET (REVENUE AND NUMBER OF CYCLES)

5.1 Germany IVF Market (Revenue and Number of Cycles)

5.1.1 Number of infertility clinics in Germany
5.1.2 Germany IVF Market by End User

5.1.2.1 Fertility clinics
5.1.2.2 Hospitals
5.1.2.3 Surgical centers
5.1.2.4 Clinical research institutes

5.1.3 Germany IVF market by cycle type

5.1.3.1 Fresh IVF cycles (non-donor)
5.1.3.2 Thawed IVF cycles (non-donor)

5.1.4 Market Dynamics

5.1.4.1 Drivers

5.1.4.1.1 SUBSIDIZING IVF TREATMENTS
5.1.4.1.2 DELAYED MARRIAGES AND PARENTHOOD DECISIONS

5.1.4.2 Restraints

5.1.4.2.1 LIMITED ADOPTION OF IVF METHODS

5.1.5 Regulatory Issues, Legislations and Authorities
5.1.6 Insurance Reimbursement Scenario
5.1.7 Company Profile

5.1.7.1 Heidelberg University Hospital
5.1.7.2 Klinikum Stuttgart
5.1.7.3 DRK Kliniken Berlin
5.1.7.4 University Medical Center Freiburg

5.2 France IVF Market (Revenue and Number of Cycles)

5.2.1 Number of infertility centers in France
5.2.2 France IVF Market by End User

5.2.2.1 Fertility clinics
5.2.2.2 Hospitals
5.2.2.3 Surgical centers
5.2.2.4 Clinical research institutes

5.2.3 France IVF market by cycle type

5.2.3.1 Fresh IVF cycles (non-donor)
5.2.3.2 Thawed IVF cycles (non-donor)
5.2.3.3 Donor egg IVF cycles

5.2.4 Market Dynamics

5.2.4.1 Drivers

5.2.4.1.1 RISING ADOPTION OF IVF BABIES AMONG SAME GENDER POPULATION
5.2.4.1.2 LOWER RATES OF FERTILITY

5.2.4.2 Restraints

5.2.4.2.1 STRINGENT GOVERNMENT REGULATIONS

5.2.5 Regulatory Issues, Legislations, and Authorities
5.2.6 Insurance Reimbursement Scenario
5.2.7 Company Profile

5.2.7.1 Clinique de la Muette
5.2.7.2 Hopital des metallurgists, hopital cochin

5.3 UK IVF Market (Revenue and Number of Cycles)

5.3.1 Number of infertility centers in UK
5.3.2 UK IVF Market by End User

5.3.2.1 Fertility clinics
5.3.2.2 Hospitals
5.3.2.3 Surgical centers
5.3.2.4 Clinical research institutes

5.3.3 UK IVF market by cycle type

5.3.3.1 Fresh IVF cycles (non-donor)
5.3.3.2 Thawed IVF cycles (non-donor)
5.3.3.3 Donor egg IVF cycles

5.3.4 Drivers

5.3.4.1 Commercialization of three-parent IVF procedures
5.3.4.2 Supportive Regulations

5.3.5 Restraints

5.3.5.1 Ethical Considerations

5.3.6 Regulatory Issues, Legislations and Authorities
5.3.7 Insurance Reimbursement Scenario
5.3.8 Company Profile

5.3.8.1 Lister Fertility Clinic
5.3.8.2 The Bridge Center
5.3.8.3 Chelsea and Westminster Hospital (Assisted Conception Unit)

5.4 Italy IVF Market (Revenue and Number of Cycles)

5.4.1 Italy IVF market by End users

5.4.1.1 Fertility clinics
5.4.1.2 Hospitals
5.4.1.3 Surgical centers
5.4.1.4 Clinical research institutes

5.4.2 Italy IVF market by cycle type

5.4.2.1 Fresh IVF cycles (non-donor)
5.4.2.2 Thawed IVF cycles (non-donor)

5.4.3 Market Dynamics

5.4.3.1 Drivers
5.4.3.2 Restraints

5.4.3.2.1 BAN ON SURROGACY

5.4.4 Regulatory issues, legislations and authorities
5.4.5 Insurance Reimbursement Scenario
5.4.6 Company Profile

5.4.6.1 ARC-STER srl
5.4.6.2 RAPRUI
5.4.6.3 Centre for Reproductive Medicine-Napoli

5.5 Spain IVF Market (Revenue and Number of Cycles)

5.5.1 Spain IVF Market by End Users

5.5.1.1 Fertility clinics
5.5.1.2 Hospitals
5.5.1.3 Surgical centers
5.5.1.4 Clinical research institutes

5.5.2 Spain IVF Market by Cycle Type

5.5.2.1 Fresh IVF cycles (non-donor)
5.5.2.2 Thawed IVF cycles (non-donor)
5.5.2.3 Donor egg IVF cycles

5.5.3 Market Dynamics

5.5.3.1 Drivers

5.5.3.1.1 INCREASE IN THE NUMBER OF FOREIGN PATIENTS

5.5.3.2 Restraints

5.5.4 Regulatory Issues, Legislations and Authorities
5.5.5 Insurance Reimbursement Scenario
5.5.6 Company Profiles

5.5.6.1 IVF spain
5.5.6.2 Clnica EUGIN Barcelona

5.6 Denmark IVF Market (Revenue and Number Of Cycles)

5.6.1 Denmark IVF Market by End Users

5.6.1.1 Fertility clinics
5.6.1.2 Hospitals
5.6.1.3 Surgical centers
5.6.1.4 Clinical research institutes

5.6.2 Denmark IVF market by cycle type

5.6.2.1 Fresh IVF cycles (non-donor)
5.6.2.2 Thawed IVF cycles (non-donor)
5.6.2.3 Donor egg IVF cycles

5.6.3 Drivers

5.6.3.1 Increase in disposable income
5.6.3.2 Advances in IVF technology

5.6.4 Restraints
5.6.5 Regulatory Issues, Legislations and Authorities
5.6.6 Insurance Reimbursement Scenario
5.6.7 Company Profiles

5.6.7.1 Copenhagen Fertility Center
5.6.7.2 Storkklinik v/Nina Stork
5.6.7.3 Vitanova
5.6.7.4 trianglen fertility clinic
5.6.7.5 Nordica - Denmark, Copenhagen

5.7 Russia IVF Market (Revenue and Number of Cycles)

5.7.1 Russia IVF Market by End Users

5.7.1.1 Fertility clinics
5.7.1.2 Hospitals
5.7.1.3 Surgical centers
5.7.1.4 Clinical research institutes

5.7.2 Russia IVF market by cycle type

5.7.2.1 Fresh IVF cycles (non-donor)
5.7.2.2 Thawed IVF cycles (non-donor)
5.7.2.3 Donor egg IVF cycles

5.7.3 Drivers

5.7.3.1 Rising popularity of fertility tourism

5.7.4 Restraints

5.7.4.1 Inadequate reimbursement policies

5.7.5 Regulatory Issues, Legislations, and Authorities
5.7.6 Insurance Reimbursement Scenario
5.7.7 Company Profiles

5.7.7.1 ava-peter clinic
5.7.7.2 md medical group
5.7.7.3 ivf russia (The International Centre of the Reproductive Medicines)

5.8 Rest of Europe IVF Market (Revenue and Number of Cycles)

5.8.1 Rest of Europe IVF Market by End User

5.8.1.1 Fertility clinics
5.8.1.2 Hospitals
5.8.1.3 Surgical centers
5.8.1.4 Clinical research institutes

5.8.2 Drivers

5.8.2.1 Wide availability of reimbursements
5.8.2.2 Changes in Lifestyle

5.8.3 Restraints
5.8.4 Regulatory Issues, Legislations and Authorities
5.8.5 Insurance Reimbursement Scenario
5.8.6 Company Profiles

5.8.6.1 Gynaecoloqisch Centrum
5.8.6.2 centrum voor medische genetica
5.8.6.3 Infertility-Vestliitto

Chapter: 6 ASIA-PACIFIC IVF MARKET (REVENUE AND NUMBER OF CYCLES)

6.1 India IVF Market (Revenue and Number of Cycles)

6.1.1 India IVF Market by End Users

6.1.1.1 Fertility clinics
6.1.1.2 Hospitals
6.1.1.3 Surgical centers
6.1.1.4 Clinical research institutes

6.1.2 India IVF market by cycle type

6.1.2.1 Fresh IVF cycles (non-donor)
6.1.2.2 Thawed IVF cycles (non-donor)
6.1.2.3 Donor egg IVF cycles

6.1.3 Market Dynamics

6.1.3.1 Drivers
6.1.3.2 Restraints

6.1.4 Regulatory Issues, Legislations and Authorities
6.1.5 Insurance Reimbursement Scenario
6.1.6 Company Profile

6.1.6.1 Bourn Hall Clinic
6.1.6.2 Southend Fertility and IVF Centre
6.1.6.3 Morpheus IVF Fertility Center
6.1.6.4 Bloom Fertility Center
6.1.6.5 Manipal Ankur
6.1.6.6 Cloudnine
6.1.6.7 Nova IVI Fertility

6.2 China IVF Market (Revenue and Number of Cycles)

6.2.1 China IVF Market by End User

6.2.1.1 Fertility clinics
6.2.1.2 Hospitals
6.2.1.3 Surgical centers
6.2.1.4 Clinical research institutes

6.2.2 China IVF market by cycle type

6.2.2.1 Fresh IVF cycles (non-donor)
6.2.2.2 Thawed IVF cycles (non-donor)
6.2.2.3 Donor egg IVF cycles

6.2.3 Market Dynamics

6.2.3.1 Drivers

6.2.3.1.1 CHANGE IN LIFESTYLE

6.2.3.2 Restraints

6.2.3.2.1 ONE CHILD POLICY

6.2.4 Regulatory Issues, Legislations and Authorities
6.2.5 Insurance Reimbursement Scenario
6.2.6 Company profile

6.2.6.1 Reproductive and genetic Hospital Citic-Xiangya
6.2.6.2 Shenyang Hospital
6.2.6.3 Shandong Provincial Hospital
6.2.6.4 Centre for Reproductive Medicine

6.3 Japan IVF Market (Revenue and Number of Cycles)

6.3.1 Japan IVF Market by End User

6.3.1.1 Fertility clinics
6.3.1.2 Hospitals
6.3.1.3 Surgical centers
6.3.1.4 Clinical research institutes

6.3.2 Japan IVF Market by Cycle Type

6.3.2.1 Fresh IVF cycles (non-donor)
6.3.2.2 Thawed IVF cycles (non-donor)

6.3.3 Market Dynamics

6.3.3.1 Drivers
6.3.3.2 Restraints

6.3.4 Regulatory Issues, Legislations, and Authorities
6.3.5 Insurance Reimbursement Scenario
6.3.6 Company Profile

6.3.6.1 EMD Serono, Inc.
6.3.6.2 IVF NAMBA Clinic
6.3.6.3 Iwaki Womens Clinic
6.3.6.4 Sanno Hospital

6.4 Australia IVF Market (Revenue and Number of Cycles)

6.4.1 Australia IVF Market by End User

6.4.1.1 Fertility clinics
6.4.1.2 Hospitals
6.4.1.3 Surgical centers
6.4.1.4 Clinical research institutes

6.4.2 Australia IVF Market by Cycle Type

6.4.2.1 Fresh IVF cycles (non-donor)
6.4.2.2 Thawed IVF cycles (non-donor)

6.4.3 Market Dynamics

6.4.3.1 Drivers
6.4.3.2 Restraints

6.4.3.2.1 EMOTIONAL AND PHYSICAL STRESS
6.4.3.2.2 NO GUARANTEE FOR THE SUCCESSFUL TREATMENTS
6.4.3.2.3 SURPLUS EMBRYOS

6.4.4 Regulatory Issues, Legislations, and Authorities
6.4.5 Insurance Reimbursement Scenario
6.4.6 Company Profile

6.4.6.1 Genea Biomedx
6.4.6.2 Thermo Fisher Scientific Inc.
6.4.6.3 Virtus Health limited
6.4.6.4 Monash IVF
6.4.6.5 City Fertility center, brisbane
6.4.6.6 Flinders Fertility clinic

6.5 New Zealand IVF Market (Revenue and Number of Cycles)

6.5.1 New Zealand IVF Market by End User

6.5.1.1 Fertility clinics
6.5.1.2 Hospitals
6.5.1.3 Surgical centers
6.5.1.4 Clinical research institutes

6.5.2 New Zealand IVF Market by Cycle Type

6.5.2.1 Fresh IVF cycles (non-donor)
6.5.2.2 Thawed IVF cycles (non-donor)
6.5.2.3 Donor egg IVF cycles

6.5.3 Market Dynamics

6.5.3.1 Drivers
6.5.3.2 Restraints

6.5.4 Regulatory Issues, Legislations, and Authorities
6.5.5 Insurance Reimbursement Scenario
6.5.6 Company Profiles

6.5.6.1 Fertility Associates
6.5.6.2 Fertility Plus
6.5.6.3 Repromed

6.6 Korea IVF Market (Revenue and Number of Cycles)

6.6.1 Korea IVF Market by End User

6.6.1.1 Fertility clinics
6.6.1.2 Hospitals
6.6.1.3 Surgical centers
6.6.1.4 Clinical research institutes

6.6.2 Korea IVF market by cycle type

6.6.2.1 Fresh IVF cycles (non-donor)
6.6.2.2 Thawed IVF cycles (non-donor)
6.6.2.3 Donor egg IVF cycles

6.6.3 Market Dynamics

6.6.3.1 Drivers
6.6.3.2 Restraints

6.6.4 Regulatory Issues, Legislations, and Authorities
6.6.5 Insurance Reimbursement Scenario
6.6.6 Company Profiles

6.6.6.1 Cha General Hospital
6.6.6.2 MARIA Fertility Hospital

6.7 Thailand IVF Market (Revenue and number of Cycles)

6.7.1 Thailand IVF Market by End User

6.7.1.1 Fertility clinics
6.7.1.2 Hospitals
6.7.1.3 Surgical centers
6.7.1.4 Clinical research institutes

6.7.2 Thailand IVF Market by Cycle Type

6.7.2.1 Fresh IVF cycles (non-donor)
6.7.2.2 Thawed IVF cycles (non-donor)
6.7.2.3 Donor egg IVF cycles

6.7.3 Market Dynamics

6.7.3.1 Drivers

6.7.3.1.1 GOVERNMENT INITIATIVES
6.7.3.1.2 ECONOMIC CONSIDERATIONS
6.7.3.1.3 BOOST IN MEDICAL TOURISM

6.7.3.2 Restraints

6.7.3.2.1 COMPARATIVELY LOW SUCCESS RATE
6.7.3.2.2 ETHICAL ISSUES IN ALLOWING GENDER SELECTION

6.7.4 Regulatory Issues, Legislations, and Authorities
6.7.5 Insurance Reimbursement Scenario
6.7.6 Company Profiles

6.7.6.1 Bangkok Fertility Center
6.7.6.2 Siriraj Hospital
6.7.6.3 Ramathibodi Hospital
6.7.6.4 Perfect Woman Institute
6.7.6.5 Jetanin Institute for Assisted Reproduction

6.8 Rest of Asia-Pacific IVF Market (Revenue and Number of Cycles)

6.8.1 Rest of Asia-Pacific IVF Market by End User

6.8.1.1 Fertility clinics
6.8.1.2 Hospitals
6.8.1.3 Surgical centers
6.8.1.4 Clinical research institutes

6.8.2 Drivers

6.8.2.1 Increase in disposable income
6.8.2.2 Advances in IVF technology
6.8.2.3 Decline in fertility rate

6.8.3 Restraints

6.8.3.1 Physical and emotional impact due to low success rate

6.8.4 Regulatory Issues, Legislations, and Authorities
6.8.5 Insurance Reimbursement Scenario
6.8.6 Company Profiles

6.8.6.1 Fertility Centre, Siloam Hospitals Surabana
6.8.6.2 CRM-MIA-Philippines
6.8.6.3 IVFAS

Chapter: 7 LAMEA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

7.1 Latin America IVF Market (Revenue and Number of Cycles)

7.1.1 Number of Infertility Centers
7.1.2 Latin America IVF Market by End User

7.1.2.1 Fertility clinics
7.1.2.2 Hospitals
7.1.2.3 Surgical centers
7.1.2.4 Clinical research institutes

7.1.3 Latin America IVF market by cycle type

7.1.3.1 Fresh IVF cycles (non-donor)
7.1.3.2 Thawed IVF cycles (non-donor)
7.1.3.3 Donor egg IVF cycles

7.1.4 Drivers

7.1.4.1 Rising Medical Tourism in Latin America
7.1.4.2 Permission for IVF treatments in Costa Rica

7.1.5 Restraints

7.1.5.1 High infant mortality rates in Brazil

7.1.6 Regulatory Issues, Legislations, and Authorities
7.1.7 Insurance Reimbursement Scenario
7.1.8 Profiles of Major Players

7.1.8.1 Clinica Anglo Americana
7.1.8.2 IVF Panama Centro De Reproduccion
7.1.8.3 Insemer
7.1.8.4 Almater Hospital
7.1.8.5 San Fernando Hospital

7.2 Middle East IVF Market (Revenue and Number of Cycles)

7.2.1 Number of Infertility Centers
7.2.2 Middle East IVF Market by End User

7.2.2.1 Fertility clinics
7.2.2.2 Hospitals
7.2.2.3 Surgical centers
7.2.2.4 Clinical research institutes

7.2.3 Middle East IVF Market by Cycle Type

7.2.3.1 Fresh IVF cycles (non-donor)
7.2.3.2 Thawed IVF cycles (non-donor)
7.2.3.3 Donor egg IVF cycles

7.2.4 Market Dynamics

7.2.4.1 Drivers

7.2.4.1.1 HIGH-TECH CULTURE
7.2.4.1.2 AVAILABILITY OF REIMBURSEMENTS

7.2.4.2 Restraints

7.2.4.2.1 STRINGENT GOVERNMENT REGULATIONS

7.2.5 Regulatory Issues, Legislations, and Authorities
7.2.6 Insurance Reimbursement Scenario
7.2.7 Company Profile

7.2.7.1 Cyprus IVF Centre
7.2.7.2 Al Bushra Medical Specialty Complex
7.2.7.3 Reproductive Medicine Unit at Corniche Hospital (Corniche Fertility center)
7.2.7.4 Trakya University Hospital ART Center

7.3 Africa IVF Market (Revenue and Number of Cycles)

7.3.1 Number of Infertility Centers
7.3.2 Africa IVF Market by End User

7.3.2.1 Fertility clinics
7.3.2.2 Hospitals
7.3.2.3 Surgical centers
7.3.2.4 Clinical research institutes

7.3.3 Africa IVF Market by Cycle Type

7.3.3.1 Fresh IVF cycles (non-donor)
7.3.3.2 Thawed IVF cycles (non-donor)
7.3.3.3 Donor egg IVF cycles

7.3.4 Drivers

7.3.4.1 Low costs of IVF treatment
7.3.4.2 Rising Fertility Tourism in South Africa

7.3.5 Restraints

7.3.5.1 Susceptibility toward fibroids

7.3.6 Regulatory Issues, Legislations, and Authorities
7.3.7 Insurance Reimbursement Scenario
7.3.8 Company Profile

7.3.8.1 Lifesure Fertility & Gynaecology Centre
7.3.8.2 Bethany Women and Family Hospital
7.3.8.3 BioART Fertility Centre
7.3.8.4 DEL International Hospital & Fertility Centre
7.3.8.5 Gift ov life
7.3.8.6 Durban Fertility Clinic
7.3.8.7 Cape fertility clinic

List of Figures

FIG. 1 GLOBAL IVF MARKET, BY FERTILITY CLINICS, VOLUME, AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 2 WORLD IVF MARKET, BY HOSPITAL, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 3 WORLD IVF MARKET, BY SURGICAL CENTER, VOLUME AND VALUE, 2014-022, (THOUSAND, $MILLION)
FIG. 4 GLOBAL IVF MARKET, BY CLINICAL RESEARCH INSTITUTE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 5 WORLD IVF MARKET, BY FRESH IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 6 WORLD IVF MARKET, BY THAWED IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 7 WORLD IVF MARKET, BY DONOR EGG IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 8 WORLD IVF MARKET, BY GEOGRAPHY, 20152022 ($MILLION)
FIG. 9 WORLD IVF MARKET, BY GEOGRAPHY, 20152022 (THOUSAND)
FIG. 10 U.S. IVF MARKET, BY FERTILITY CLINICS, VOLUME, AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 11 U.S. IVF MARKET, BY HOSPITAL, VOLUME AND, VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 12 U.S. IVF MARKET, BY SURGICAL CENTER, 20142022, VOLUME AND VALUE (THOUSAND, $MILLION)
FIG. 13 U.S. IVF MARKET, BY CLINICAL RESEARCH INSTITUTE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 14 U.S. IVF MARKET, BY FRESH IVF CYCLE, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 15 U.S. IVF MARKET, BY THAWED IVF CYCLE, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
FIG. 16 U.S. IVF MARKET, BY DONOR EGG IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 17 ART REGULATORY SCENARIO, U.S.
FIG. 18 CANADIAN IVF MARKET, BY FERTILITY CLINIC, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 19 CANADIAN IVF MARKET, BY HOSPITAL, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 20 CANADIAN IVF MARKET, BY SURGICAL CENTER, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 21 CANADIAN IVF MARKET, BY CLINICAL RESEARCH INSTITUTE, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 22 CANADIAN IVF MARKET, BY FRESH IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 23 CANADIAN IVF MARKET, BY THAWED IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 24 CANADIAN IVF MARKET, BY DONOR EGG IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 25 ART REGULATORY SCENARIO, CANADA
FIG. 26 MEXICAN IVF MARKET, BY FERTILITY CLINIC, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 27 MEXICAN IVF MARKET, BY HOSPITAL, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 28 MEXICAN IVF MARKET, BY SURGICAL CENTER, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 29 MEXICAN IVF MARKET, BY CLINICAL RESEARCH INSTITUTE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 30 MEXICAN IVF MARKET, BY FRESH IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 31 MEXICAN IVF MARKET, BY THAWED IVF CYCLE, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 32 MEXICAN IVF MARKET, BY DONOR EGG IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 33 ART REGULATORY SCENARIO, MEXICO
FIG. 34 GERMANY: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 35 GERMANY: IVF MARKET, BY HOSPITAL, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 36 GERMANY: IVF MARKET, BY SURGICAL CENTER, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 37 GERMANY: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 38 GERMANY: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 39 GERMANY: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 40 REGULATORY SCENARIO, GERMANY
FIG. 41 FRANCE: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 42 FRANCE: IVF MARKET, BY HOSPITALS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 43 FRANCE: IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 44 FRANCE: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 45 FRANCE: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 46 FRANCE: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 47 FRANCE: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 48 REGULATORY SCENARIO, FRANCE
FIG. 49 UK IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
FIG. 50 UK IVF MARKET, BY HOSPITALS

License Type
Single User PDF
Enterprise Online /PDF
Price
User / Sharing
Restricted to one authorized user
Unlimited within company / enterprise
Printing
One Print only
Unlimited within company / enterprise
Delivery Formats
ADDED BENIFITS

20% Free customization (Pre-sale)

16 Analyst hour support (Post Sale)

40 Analyst hour support (Post Sale)

160 hours of mini-consult

Free quarterly industry update

Free report on update (within 180 days)

MULTIPLE PURCHASE

Complimentary report with 2 reports

Complimentary report with 3 reports

Subscription Model

 
 

Are You?

  • Startup
  • Student or University
  • Research Scholar
  • Government Agencies
  • Non-profit Organization
  • NGO / Self Help Group
  • First Time Buyer

Get Discount     btn-arrow

Please Select Format

Need More Information

Why Progressive Markets

The market research services provided by Progressive Market Research (PMR) are restricted to publications, which may also include insignificant market data. The services are for the internal use of customers only and they do not have any rights to utilize this data for general publications or/and disclosure to third parties. As data is gathered through research activities such as online surveys and interviews of industry experts, it may have variations and fluctuation due to constantly changing market conditions. Thus, Progressive Market Research holds no responsibility of misleading or false information gathered from these sources.

Progressive Market Research understands and resp

Recently Viewed Reports

Similar Market Research Report

blog
Jun
2017
Global Baby Drinks Market

Baby drinks includes infant formulas and vegetables & fruit juices suitable for consumption by children up to three years of age. Infant formulas consist of vitamins & minerals, carbohydrates, proteins, ... Read More >>

 

Get Email Alert